openPR Logo
Press release

Entacapone Market Is Likely to Experience a Tremendous Growth by 2031

11-27-2024 07:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Entacapone Market Is Likely to Experience a Tremendous Growth

Entacapone market is anticipated to grow at a significant CAGR during the forecast period. Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the market is the increasing prevalence of Parkinson disease.

According to the Parkinson Foundation, almost one million people are living with Parkinson disease in the US which is expected to rise to 1.2 million in 2030. Additionally, approximately 60,000 Americans are diagnosed with PD each year and more than 10 million people are living with PD globally. Further, PD disease increases with age however, an estimated 4% of people with PD are diagnosed before age 50. Moreover, the prevalence of PD in men are 1.5 times as compared to women. However, increasing cost for the treatment of PD is hampering the growth of the global entacapone market during the forecast period.

Some major key players in the market include Novartis International AG, Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, STADA declared European launch of the Lecigon triple-combination of levodopa, carbidopa, and entacapone for treating advanced Parkinson's disease.

To Request a Sample of our Report on Entacapone Market:  https://www.omrglobal.com/request-sample/entacapone-market

Segment Covered- 

By Product
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape-Novartis International AG, Teva Pharmaceutical Industries Ltd.,and Sun Pharmaceutical Industries Ltd., among others.

Entacapone Market Report by Segment

By Product 

Purity:98%
Purity: above 98%

By Application 

Tablet Product
Capsule Product
Others

A full Report of Entacapone Market is Available @  https://www.omrglobal.com/industry-reports/entacapone-market

Entacapone Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/entacapone-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Entacapone Market Is Likely to Experience a Tremendous Growth by 2031 here

News-ID: 3760090 • Views:

More Releases from Orion Market Research

Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033
Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Fo …
In 2024, the global Mobile Gamma Cameras Market was valued at approximately USD 57.8 million, and it is expected to reach USD 79.2 million by 2033, reflecting a compound annual growth rate (CAGR) of around 3.39% between 2025 and 2033. Mobile Gamma Cameras Market Overview The Mobile Gamma Cameras Market is seeing steady growth, with demand rising across oncology, cardiology, and nuclear medicine due to its ability to provide portable,
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare Services AG, Osstem Implant, BioHorizons, MIS Implants Technologies
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare …
In 2024, the global Dental Implants Market was valued at approximately USD 6.8 billion, and it is projected to reach USD 9.8 billion by 2033, representing a compound annual growth rate (CAGR) of around 4.2% from 2025 to 2033. Dental Implants Market Overview The Dental Implants Market is experiencing robust growth driven by rising global incidences of tooth loss, heightened demand for aesthetic and permanent dental solutions, and rapid technological advancements-such
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dickinson and Company (BD), PerkinElmer Inc., Merck KGaA
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dic …
In 2024, the global Cell-based Assays Market is estimated at approximately USD 24.1 billion, and it is forecast to reach USD 45.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 6.9% from 2025 to 2033. Cell-based Assays Market Overview The Cell-based Assays Market is witnessing sustained growth driven by increased demand from drug discovery, disease modeling, and safety/toxicity testing. These assays-crucial in early-stage pharmaceutical R&D-offer biologically relevant
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce, Qlik Technologies, MicroStrategy Incorporated
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033. Business Analytics Market Overview The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,

All 5 Releases


More Releases for Entacapone

Entacapone Market Trends, Segmentation, Growth, Analysis and Forecast 2023-2029
The global entacapone market is anticipated to grow at a significant CAGR during the forecast period. Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the
2022 Entacapone Market Report- High Growth Advancement, Emerging Trends, Compreh …
The Entacapone Market research report provides a 360-degree view of the market by examining political, social, monetary and technological advancements boosting the Entacapone Market growth. Entacapone Market also covers the rising evaluation of market growth and provides inclusive data about all opportunities and risks related to the global Entacapone Market during the projected period. Moreover, the Entacapone Market research report covers all the key events and most recent innovations in
Entacapone Market Size & Growth Analysis Report, 2021-2027
The global entacapone market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of
Entacapone Market to Eyewitness Stunning Growth by 2027 | Fermion, RXN Chemicals
This Entacapone market study uses a few important techniques, such as consumer surveys, in-depth discussions, and focus groups, to get information on current industry trends, emerging markets, and factors that influence market growth. It also provides guidance on what should be considered prior to the release of new products. All of this market data assists large corporations in making crucial judgments are included in this market report. Get Sample Copy of
Global Entacapone Market Expected to Witness a Sustainable Growth over 2024– T …
Market Research Report Store offers a latest published report on Entacapone Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Entacapone players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Entacapone with respect to individual growth trends, future prospects,
Global Entacapone Market Insights, Industry Player (Fermion, ACIC Pharmaceutical …
Market Research Hub (MRH) has actively included a new research study titled “Global Entacapone Market” Size, Status and Forecast 2018-2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025.